Overview

Efficacy and Safety of Hydromorphone Hydrochloride Extended-Release Compared to Placebo in Subjects With Persistent Pain

Status:
Terminated
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to assess the efficacy and safety of 8 mg Hydromorphone Hydrochloride Extended-Release.
Phase:
Phase 3
Details
Lead Sponsor:
Purdue Pharma LP
Treatments:
Hydromorphone